Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

Robert P. Cowan, Michael J. Marmura, Hans-Christoph Diener, Amaal J. Starling, Jack Schim, Joe Hirman, Thomas Brevig, Roger Cady

Open source

DOI: 10.1186/s10194-022-01482-0
Published: 2022-09-06
Container: The Journal of Headache and Pain
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s10194-022-01482-0,
  title = {Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study},
  author = {Robert P. Cowan and Michael J. Marmura and Hans-Christoph Diener and Amaal J. Starling and Jack Schim and Joe Hirman and Thomas Brevig and Roger Cady},
  year = {2022},
  journal = {The Journal of Headache and Pain},
  doi = {10.1186/s10194-022-01482-0},
  url = {https://doi.org/10.1186/s10194-022-01482-0}
}

RIS

TY  - JOUR
TI  - Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study
AU  - Robert P. Cowan
AU  - Michael J. Marmura
AU  - Hans-Christoph Diener
AU  - Amaal J. Starling
AU  - Jack Schim
AU  - Joe Hirman
AU  - Thomas Brevig
AU  - Roger Cady
PY  - 2022
JO  - The Journal of Headache and Pain
DO  - 10.1186/s10194-022-01482-0
UR  - https://doi.org/10.1186/s10194-022-01482-0
ER  -

APA

Cowan, R. P., Marmura, M. J., Diener, H., Starling, A. J., Schim, J., Hirman, J., Brevig, T., & Cady, R. (2022). Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-022-01482-0

Source records

crossref · retrieved 2026-09-26T18:51:20.842Z